Drug Profile
Parathyroid hormone 7-34
Alternative Names: Parathyroid hormone 7-34 - IGI; PTH (7-34); PTH 7-34; PTHrP (7-34)Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator IGI
- Developer Boston University; Teligent
- Class Chemoprotectants; Peptide fragments; Peptide hormones
- Mechanism of Action Parathyroid hormone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alopecia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alopecia in USA (Topical, Cream)
- 09 May 2007 IGI receives STTR grant from the US National Cancer Institute for development of PTH 7-34 in chemotherapy-induced Alopecia
- 13 Dec 2005 IGI has extended its exclusive license from Novavax for the use of Novasome® lipid vesicle encapsulation technology, micellar nanoparticles, and the Ultrasponge® Technology until December 2015